PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Powiadomienia systemowe
  • Sesja wygasła!
  • Sesja wygasła!
Tytuł artykułu

Characterization of a commercial EPID-based in-vivo dosimetry and its feasibility and implementation for treatment verification in Malaysia

Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Introduction: In vivo dosimetry verification is currently a necessity in radiotherapy centres in Europe countries as one of the tools for patient-specific QA, and now its demand is currently rising in developed countries, such as Malaysia. The aim of this study is to characterize commercial EPID-based dosimetry and its implementation for radiotherapy treatment verification in Malaysia. Materials and Methods: In this work, the sensitivity and performance of a commercially available in vivo dosimetry system, EPIgray® (DOSIsoft, Cachan, France), were qualitatively evaluated prior to its use at our centre. EPIgray response to dose linearity, field size, off-axis, position, and angle dependency tests were performed against TPS calculated dose for 6 MV and 10 MV photon beams. Relative deviations of the total dose were evaluated at isocentre and different depths in the water. EPIgray measured dose was validated by using IMRT and VMAT prostate plan. All calculation points were at the beam isocentre and at points suggested by TG-119 with accepted tolerance of ±10% dose threshold. Results: EPIgray reported good agreement for linearity, field size, off-axis, and position dependency with TPS dose, being within 5% tolerance for both energy ranges. The average deviation was less than ±2% and ±7% in 6 MV and 10 MV photon beams, respectively, for the angle dependency test. A clinical evaluation performed for the IMRT prostate plan gave average agreement within ±3% at the plan isocentre for both energies. While for the VMAT plan, 95% and 100% of all points created lie below ±5% for 6 MV and 10 MV photon beam energy, respectively. Conclusion: In summary, based on the results of preliminary characterization, EPID-based dosimetry is believed as an important tool and beneficial to be implemented for IMRT/VMAT plans verification in Malaysia, especially for in vivo verification, alongside existing pre-treatment verification.
Rocznik
Strony
215--221
Opis fizyczny
Bibliogr. 25 poz., rys.
Twórcy
  • School of Physics, USM, 11800 Minden, Penang, Malaysia
  • School of Physics, USM, 11800 Minden, Penang, Malaysia
  • Department of Radiotherapy and Oncology, Gleneagles Medical Centre, 10050 George Town, Penang, Malaysia
  • School of Physics, USM, 11800 Minden, Penang, Malaysia
  • School of Physics, USM, 11800 Minden, Penang, Malaysia
Bibliografia
  • 1. Hizam ND, Ung NM, Jong WL, et al. Medical physics aspects of intensity-modulated radiotherapy practice in Malaysia. Physica Medica. 2019;67:34-39. https://doi.org/10.1016/j.ejmp.2019.10.023
  • 2. van der Veen J, Laenen A, Nuyts S. Modern radiotherapy techniques versus three-dimensional conformal radiotherapy for head and neck cancer. Cochrane Database of Systematic Reviews. 2017. https://doi.org/10.1002/14651858.cd012904
  • 3. Das IJ, Moskvin V, Johnstone PA. Analysis of treatment planning time among systems and planners for intensity-modulated radiation therapy. Journal of the American College of Radiology. 2009;6(7):514-517. https://doi.org/10.1016/j.jacr.2008.12.013
  • 4. Wolff D, Stieler F, Welzel G, et al. Volumetric modulated arc therapy (VMAT) vs. Serial Tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiotherapy and Oncology. 2009;93(2):226-233. https://doi.org/10.1016/j.radonc.2009.08.011
  • 5. Elith C, Dempsey SE, Findlay N, Warren-Forward HM. An introduction to the intensity-modulated radiation therapy (IMRT) techniques, tomotherapy, and VMAT. Journal of Medical Imaging and Radiation Sciences. 2011;42(1):37-43. https://doi.org/10.1016/j.jmir.2010.11.005
  • 6. Abolaban F, Zaman S, Cashmore J, Nisbet A, Clark C. Changes in patterns of intensity-modulated radiotherapy verification and quality assurance in the UK. Clin Oncol. 2016;28(8):e28-34. https://doi.org/10.1016/j.clon.2016.01.013
  • 7. Mijnheer BJ, Alber ML. Guidelines for the Verification of IMRT. Brussels: ESTRO; 2008
  • 8. McCurdy BM. Dosimetry in radiotherapy using a-Si EPIDs: Systems, methods, and applications focusing on 3D patient dose estimation. Journal of Physics: Conference Series. 2013;444:012002. https://doi.org/10.1088/1742-6596/444/1/012002
  • 9. Kavuma A, Glegg M, Currie G, Elliott A. Assessment of dosimetrical performance in 11 Varian a-SI500 Electronic Portal Imaging Devices. Physics in Medicine and Biology. 2008;53(23):6893-6909. https://doi.org/10.1088/0031-9155/53/23/016
  • 10. McCurdy BM, Greer PB. Dosimetric properties of an amorphous-silicon epid used in continuous acquisition mode for application to dynamic and ARC IMRT. Medical Physics. 2009;36(7):3028-3039. https://doi.org/10.1118/1.3148822
  • 11. Mans A, Wendling M, McDermott LN, et al. Catching errors within vivo EPID dosimetry. Medical Physics. 2010;37(6Part2):2638-2644. https://doi.org/10.1118/1.3397807
  • 12. Ricketts K, Navarro C, Lane K, et al. Implementation and evaluation of a transit dosimetry system for treatment verification. Physica Medica. 2016;32(5):671-680. https://doi.org/10.1016/j.ejmp.2016.04.010
  • 13. DOSIsoft EPIgray Edition 2.0 Practical Guide V1.5. Upgraded versions of Patient Quality Assurance Solutions. DOSIsoft. https://www.dosisoft.com/2021/07/22/upgraded-versions-patient-quality-assurance-solutions/. Published July 22, 2021. Accessed July 14, 2022
  • 14. DOSIsoft EPIgray Edition 2.0.6 Data preparation V3.4. EPIgray®*. DOSIsoft. https://www.dosisoft.com/products/epigray/. Accessed July 14, 2022
  • 15. Mijnheer B. EPIDs and QA of advanced treatments. Journal of Physics: Conference Series. 2019;1305:012061. https://doi.org/10.1088/1742-6596/1305/1/012061
  • 16. Francois P, Boissard P, Berger L, Mazal A. In vivo dose verification from back projection of a transit dose measurement on the central axis of photon beams. Physica Medica. 2011;27(1):1-10. https://doi.org/10.1016/j.ejmp.2010.06.002
  • 17. Ezzell GA, Burmeister JW, Dogan N, et al. IMRT commissioning: Multiple Institution Planning and dosimetry comparisons, a report from AAPM Task Group 119. Medical Physics. 2009;36(11):5359-5373. https://doi.org/10.1118/1.3238104
  • 18. Moore JA, Siebers JV. Verification of the optimal backscatter for an aSi electronic portal imaging device. Phys Med Biol. 2005;50(10):2341-2350. https://doi.org/10.1088/0031-9155/50/10/011
  • 19. Rowshanfarzad P, McCurdy B, Sabet M, Lee C, O'Connor D, Greer P. Measurement and modeling of the effect of support arm backscatter on dosimetry with a Varian EPID. Med Phys. 2010;37(5):2269-2278. https://doi.org/10.1118/1.3369445
  • 20. Bojechko C, Ford EC. Quantifying the performance of in vivo portal dosimetry in detecting four types of treatment parameter variations. Medical Physics. 2015;42(12):6912-6918. https://doi.org/10.1118/1.4935093
  • 21. Celi S, Costa E, Wessels C, Mazal A, Fourquet A, Francois P. Epid based in vivo dosimetry system: Clinical experience and results. Journal of Applied Clinical Medical Physics. 2016;17(3):262-276. https://doi.org/10.1120/jacmp.v17i3.6070
  • 22. Held M, Cheung J, Perez Andujar A, Husson F, Morin O. Commissioning and evaluation of an electronic portal imaging device-based in-vivo dosimetry software. Cureus. 2018;10(2):e2139. https://doi.org/10.7759/cureus.2139
  • 23. Woodruff HC, Fuangrod T, Van Uytven E, et al. First experience with real-time epid-based delivery verification during IMRT and VMAT sessions. International Journal of Radiation Oncology Biology Physics. 2015;93(3):516-522. https://doi.org/10.1016/j.ijrobp.2015.07.2271
  • 24. Spreeuw H, Rozendaal R, Olaciregui-Ruiz I, et al. Online 3D epid-based dose verification: Proof of concept. Medical Physics. 2016;43(7):3969-3974. https://doi.org/10.1118/1.4952729
  • 25. Olaciregui-Ruiz I, Beddar S, Greer P, et al. In vivo dosimetry in external beam photon radiotherapy: Requirements and future directions for research, development, and clinical practice. Physics and Imaging in Radiation Oncology. 2020;15:108-116. https://doi.org/10.1016/j.phro.2020.08.003
Uwagi
Opracowanie rekordu ze środków MEiN, umowa nr SONP/SP/546092/2022 w ramach programu "Społeczna odpowiedzialność nauki" - moduł: Popularyzacja nauki i promocja sportu (2022-2023).
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-c980370c-044b-4c63-89e9-28eba48c3acf
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.